Institute for Cardiogenetics - University of Lübeck
The Institute for Cardiogenetics at the University of Lübeck invites applications for 3 years (PhD) or 2.5 years (Postdoc). The position is embedded in the DFG-funded Research UnitFOR 5930 a multidisciplinary collaboration arround Athero-Immunology between research institutions in Lübeck Berlin Borstel and Kiel.
About the Institute: Founded in 2013 the Institute for Cardiogenetics focuses on elucidating the genetic and molecular mechanisms of cardiovascular diseases with particular emphasis on atherosclerosis and myocardial infarction. The institute integrates advanced molecular and cellular biology multi-omics technologies animal models computational biology and bioinformatics. The institute actively collaborates within national and international research networks including: Cardiogenics CARDIoGRAMplusC4D PlaqOmics and VIAgenomics.
Project Description: The successful candidate will investigate immunological and genetic mechanisms driving atherosclerosis. The project combines: Experimental work using animal models of cardiovascular disease Molecular and cellular wet-lab techniques Spatial transcriptomics RNA-scope Single-cell RNA sequencing (scRNA-seq) and ATAC-seq computational biology
The position offers the opportunity to work at the interface of experimental cardiovascular research and integrative genomics.
Start in our team:
We are looking for professional and competent support to start as soon as possiblelimited for 3 years (PhD track) or 2.5 years (Postdoc track) with possible extension for 6 months.
What we offer:
Your tasks:
Your profile:
We are looking forward to your application including:
Please submit your application until 1st April 2026indicating the reference number28152.
Contact for Information:
PD Dr. Zouhair Aherrahrou () looks forward to speaking with you about further details concerning the position.
The University of Lübeck stands for excellence in biomedical research and education. We look forward to receiving applications from highly motivated candidates who are eager to contribute to advancing precision medicine in cardiovascular disease.